Conclusions
®
This study showed that oseltamivir phosphate for suspension (6 mg/ml after reconstitution, 75 mg/12.5 ml) and TAMIFLU® (6 mg/mL, 75 mg/12.5 ml) met bioequivalence criteria in the matter of the absorption rate and the degree of absorption of oseltamivir phosphate and oseltamivir carboxylate, and had good safety. Food had no effect on the pharmacokinetics and bioequivalence of oseltamivir phosphate for suspension and TAMIFLU® in healthy subjects.